Stress hyperglycemia in pediatric patients as a risk factor for type 1 diabetes - a single center experience

Giora Weiser1,2, Yitshak Yaniv3, Saar Hashavya2,4

  • 1Pediatric Emergency Department, 26743 Shaare Zedek Medical Center , Jerusalem, Israel.

Insights

Children with stress hyperglycemia in the emergency department face a higher risk of developing type 1 diabetes mellitus. Close follow-up is recommended for early diagnosis in these pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Emergency Medicine

Background:

  • Stress hyperglycemia is common in pediatric emergency departments, often linked to severe illnesses.
  • Previous research on the link between stress hyperglycemia and type 1 diabetes mellitus has yielded conflicting results.

Purpose of the Study:

  • To investigate the association between stress hyperglycemia in children and the subsequent development of type 1 diabetes mellitus.
  • To determine if pediatric patients with stress hyperglycemia have an increased risk for type 1 diabetes.

Main Methods:

  • A retrospective follow-up cohort study of children admitted with stress hyperglycemia between 2010-2014.
  • Evaluation of the cohort over a 10-year period for type 1 diabetes mellitus development.
  • Comparison of the study group's incidence to the general population's incidence in Israel.

Main Results:

  • 1,184 pediatric admissions with stress hyperglycemia were recorded.
  • Infectious and respiratory diseases were the most frequent associated diagnoses.
  • An odds ratio of 14.95 indicated a significantly higher risk of developing type 1 diabetes in the cohort compared to the general population.

Conclusions:

  • Pediatric patients presenting with stress hyperglycemia may have an elevated risk for type 1 diabetes mellitus.
  • Close monitoring and advanced testing are suggested for early diagnosis in at-risk children.
  • This finding highlights the importance of considering long-term metabolic implications in pediatric emergency care.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
337
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262